Coronavirus live updates: Major late-stage vaccine trial paused; drugmakers pledge to prioritize safety

Health, Fitness & Food

Nine drugmakers working on coronavirus vaccines publicly pledged on Tuesday to prioritize safety and uphold rigorous scientific standards as concerns mount of political pressure to bring a vaccine to market before the Nov. 3 U.S. presidential election. The pledge sought to “ensure public confidence” by committing to only apply for regulatory authorization when enough data has been collected from a large phase three trial. Three vaccine manufacturers have now entered phase three trials. 

The following data was compiled by Johns Hopkins University:

  • Global cases: More than 27.3 million
  • Global deaths: At least 893,00
  • U.S. cases: More than 6.3 million
  • U.S. deaths: At least 189,200

Products You May Like

Articles You May Like

Scientists question ‘strange’ data in Russian coronavirus vaccine trial after ‘unlikely’ patterns
At least 24 million students could drop out of school due to the coronavirus pandemic, UN says
Coronavirus live updates: Struggling restaurants brace for winter; WHO reports record one-day spike in cases
Europe on high alert as coronavirus cases rise and targeted lockdowns return
Public health specialists criticize Trump administration over reports it interfered with CDC studies

Leave a Reply

Your email address will not be published. Required fields are marked *